These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Structure and bioactivity of the amino-terminal fragment of pro-opiomelanocortin.
    Author: Seger MA, Bennett HP.
    Journal: J Steroid Biochem; 1986 Nov; 25(5B):703-10. PubMed ID: 3543499.
    Abstract:
    The primary sequence of the amino-terminal or 16 K fragment (16 K) of pro-opiomelanocortin (POMC) is highly conserved throughout the mammals. This suggests an important biological role for this peptide. We have performed studies to determine the structure, biosynthetic origin and bioactivity of this pituitary peptide. A comprehensive study of all the biosynthetic derivatives of POMC in the neurointermediate lobe of the rat and mouse pituitary was undertaken. Inspection of the amino acid composition of these peptides indicated that cleavage at all available dibasic processing sites within POMC is essentially complete except for Arg49-Lys50 within the 1-74 16 K fragment (16 K1-74). Only about 50% of 16 K1-74 was found to be processed to give rise to the extreme amino-terminal 1 to 49 sequence (16 K1-49) and the carboxyl-terminal 50 to 74 sequence (Lys1 gamma 3 melanotropin). Sufficient 16 K1-77 and 16 K1-49 was purified from bovine posterior pituitaries in order to determine if there are any structural features controlling the limited degree of processing of 16 K within the intermediate lobe. Both bovine 16 K1-77 and 16 K1-49 were found to have cystine bridges linking cystine residues 2 and 24 and linking cystine residues 8 and 20. While 16 K1-77 was found to be O-glycosylated at threonine45 and N-glycosylated as asparagine65, 16 K1-49 was found to have no carbohydrate content. Thus the presence of O-glycosylation at threonine45 apparently inhibits cleavage at -Arg49-Lys50-. Lys1 gamma 3 MSH 16 K1-74 and 16 K1-49 purified from rat neurointermediate pituitaries were tested for their ability to potentiate the action of corticotropin (ACTH) in an isolated rat adrenal cell bioassay. None of the 16 K-related peptides showed any intrinsic steroidogenic activity. Experiments were performed in which dispersed adrenal cells were incubated with serial dilutions of ACTH. Constant amounts of test peptides were added in concentrations ranging from 10 pM to 5 nM. Lys1 gamma 3 MSH potentiated the steroidogenic activity of ACTH by up to 2-fold with an ED50 of approx 0.5 nM. 16 K1-49 showed no ability to potentiate the action of ACTH. In contrast the most highly glycosylated form of 16 K1-74 potentiated the action of ACTH by up to 6-fold.
    [Abstract] [Full Text] [Related] [New Search]